Finance

Lists
HQY:NASDAQ
Healthequity Inc
US$ ८९.८७
-०.३५%
(-०.३२) 1D
US$ ८८.९९
-०.९८% (-०.८८)
After hours
Closed: अक्टोबर १४, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HQY...
Open
US$ ८९.८४
High
US$ ९२.७२
Low
US$ ८९.०८
Mkt. cap
७.४३ अरब
Avg. vol.
८.५६ लाख
Volume
८.२० लाख
P/E ratio
३२.४७
52-wk high
US$ १०७.६२
52-wk low
US$ ७२.७६
EPS
US$ २.७७
Beta
०.२४
Shares outstanding
८.२७ करोड
No. of employees
३ हजार
Open
US$ ८९.८४
High
US$ ९२.७२
Low
US$ ८९.०८
Mkt. cap
७.४३ अरब
Avg. vol.
८.५६ लाख
Volume
८.२० लाख
P/E ratio
३२.४७
52-wk high
US$ १०७.६२
52-wk low
US$ ७२.७६
EPS
US$ २.७७
Beta
०.२४
Shares outstanding
८.२७ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
StreetInsider
StreetInsider
·
१ दिन पहिले
Jefferies examines HealthEquity stock short interest rise
Profile
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments. Wikipedia
About Healthequity Inc
CEOJon Kessler
Employees२.८१ हजार
Founded२००२ जनवरी १
HeadquartersDraper, युटा, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to HQY in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HQY in the last 3 months.
Highest
Current US$ ८९.८७
US$ १४२.०० (+५८.०१%)
Average
US$ ११८.८९ (+३२.२९%)
Lowest
US$ १०५.०० (+१६.८४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
US$ १०८.००
+२०.२%
10/06/2026
Stan Berenshteyn
Wells Fargo
Buy
Reiterated
US$ १२५.००
+३९.१%
09/29/2026
Peter Warendorf
Barclays
Buy
Reiterated
US$ ११५.००
+२८%
09/18/2026
George Hill
Deutsche Bank
Buy
Reiterated
US$ १४२.००
+५८%
08/31/2026
Alexander Paris
Barrington
Buy
Reiterated
US$ ११०.००
+२२.४%
08/28/2026
Sean Dodge
BMO Capital
Buy
Maintained
US$ १०५.००
+१६.८%
08/28/2026
David Larsen
BTIG
Buy
Maintained
US$ ११५.००
+२८%
08/28/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
US$ १२५.००
+३९.१%
08/28/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
US$ १२५.००
+३९.१%
08/18/2026
Alexei Gogolev
J.P. Morgan
Buy
Reiterated
US$ १२३.००
+३६.९%
06/25/2026
Constantine Davides
Citizens JMP
Buy
Maintained
US$ १११.००
+२३.५%
06/01/2026
David Roman
Goldman Sachs
Sell
Maintained
US$ ८८.००
-२.१%
05/29/2026
Daniel Perlin
RBC Capital
Buy
Reiterated
US$ १००.००
+११.३%
03/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
US$ १०८.००
+२०.२%
02/19/2026
Gregory Peters
Raymond James
Buy
Reiterated
US$ १००.००
+११.३%
02/17/2026
Last report
२०२६ अगस्ट २७
Fiscal period
Q2 2027
US$ १.२४ / US$ १.१९
+३.९१%beat
Revenue / Est. (USD)
३५.०७ करोड / ३४.९२ करोड
+०.४३%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ अक्टोबर
२०२६ जनवरी
२०२६ अप्रिल
२०२६ जुलाई
Revenue
३२.२२ करोड
३३.४६ करोड
३५.४६ करोड
३५.०७ करोड
Cost of goods sold
९.४१ करोड
१०.६४ करोड
९.८३ करोड
९.२८ करोड
Cost of revenue
९.४१ करोड
१०.६४ करोड
९.८३ करोड
९.२८ करोड
Research and development expenses
६.५९ करोड
७.०४ करोड
६.७८ करोड
७.३९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५.५३ करोड
५.८४ करोड
५.८० करोड
५.८१ करोड
Operating expense
१४.८२ करोड
१५.५८ करोड
१५.२२ करोड
१५.८३ करोड
Total operating expenses
२४.२३ करोड
२६.२२ करोड
२५.०६ करोड
२५.११ करोड
Operating income
७.९९ करोड
७.२४ करोड
१०.४१ करोड
९.९७ करोड
Other non operating income
२२.०० हजार
३.२९ लाख
१.६१ लाख
२०.०० हजार
EBT including unusual items
६.७५ करोड
६.०९ करोड
९.२४ करोड
८.७९ करोड
EBT excluding unusual items
६.८७ करोड
६.२२ करोड
९.३५ करोड
८.८८ करोड
Income tax expense
१.५८ करोड
१.१२ करोड
२.३० करोड
२.२२ करोड
Effective tax rate
२३.४६%
१८.३२%
२४.८८%
२५.२९%
Other operating expenses
-
-
-
-
Net income
५.१७ करोड
४.९७ करोड
६.९४ करोड
६.५६ करोड
Net profit margin
१६.०५%
१४.८७%
१९.५७%
१८.७२%
Earnings per share
१.०१
०.९५
१.२४
१.२४
Interest and investment income
२८.६४ लाख
२७.६८ लाख
१८.८७ लाख
१७.६० लाख
Interest expense
-१.४० करोड
-१.३३ करोड
-१.२६ करोड
-१.२६ करोड
Net interest expenses
-१.१२ करोड
-१.०५ करोड
-१.०७ करोड
-१.०८ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
११.८६ करोड
११.११ करोड
१४.२३ करोड
१४.१६ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू